Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)
China flag China · Delayed Price · Currency is CNY
11.56
+0.01 (0.09%)
Apr 30, 2026, 3:04 PM CST

SHE:002900 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
396.49460.86794.07991.161,203529.83
Trading Asset Securities
91.51150.7848.0857.7591.25581.68
Cash & Short-Term Investments
488611.64842.151,0491,2941,112
Cash Growth
-32.60%-27.37%-19.71%-18.93%16.41%8.73%
Accounts Receivable
97.6783.1221.1999.46124.6132.98
Other Receivables
4.324.5713.361.730.990.64
Receivables
101.9987.67234.55101.19125.59133.62
Inventory
236.98236.76307.67208.79161.16156.55
Other Current Assets
64.2260.3987.5977.5443.0125.51
Total Current Assets
891.18996.461,4721,4361,6241,427
Property, Plant & Equipment
1,4701,4971,4021,082882.45925.35
Long-Term Investments
720.92713.2711.73708.99646.87604.5
Goodwill
0.840.841.341.340.59.44
Other Intangible Assets
131.9131.76112.95113.3761.162.5
Long-Term Deferred Tax Assets
32.1432.8725.2223.0824.6825.84
Long-Term Deferred Charges
72.8174.8266.3857.9638.410.69
Other Long-Term Assets
10.179.018.8820.22--
Total Assets
3,3303,4553,8003,4433,2783,066
Accounts Payable
221.69219.8323.48182.13120.84105.16
Accrued Expenses
10.118.4539.6878.7999.3107.57
Short-Term Debt
661.39771.23575.96275.27220.22270.28
Current Portion of Long-Term Debt
52.0471.13217.45201.5410.170.06
Current Portion of Leases
--3.353.423.44.46
Current Income Taxes Payable
2.522.330.320.040.010.02
Current Unearned Revenue
13.716.9117.7743.2554.7921.06
Other Current Liabilities
50.4945.7579.7260.618927.99
Total Current Liabilities
1,0121,1461,258845.03597.73536.61
Long-Term Debt
312.51273.28134.19229.83417.78204.84
Long-Term Leases
3.133.534.688.335.148.03
Long-Term Unearned Revenue
103.36126.35103.9179.0383.8688.96
Long-Term Deferred Tax Liabilities
131.89131.79135.8132.54120.95110.61
Total Liabilities
1,5631,6811,6361,2951,225949.04
Common Stock
316.35316.35316.36316.39316.6316.6
Additional Paid-In Capital
1,0931,0931,0901,0821,0431,073
Retained Earnings
356.68363.74766.64771.23729.21797.94
Treasury Stock
---13.14-29.54-47.79-85.77
Total Common Equity
1,7661,7732,1602,1402,0412,101
Minority Interest
1.422.094.037.7311.3215.02
Shareholders' Equity
1,7671,7752,1642,1482,0522,116
Total Liabilities & Equity
3,3303,4553,8003,4433,2783,066
Total Debt
1,0291,119935.63718.38656.73487.67
Net Cash (Debt)
-541.07-507.54-93.47330.54637.17623.84
Net Cash Growth
----48.12%2.14%-17.09%
Net Cash Per Share
-1.66-1.60-0.301.082.112.01
Filing Date Shares Outstanding
352.84320.35298.74278.39309.78309.78
Total Common Shares Outstanding
352.84320.35298.74278.39309.78309.78
Working Capital
-120.74-149.15214.23591.41,026890.58
Book Value Per Share
5.005.537.237.696.596.78
Tangible Book Value
1,6331,6402,0462,0261,9792,030
Tangible Book Value Per Share
4.635.126.857.286.396.55
Buildings
--913.01644.88635.65640.66
Machinery
--1,056799.09737.21716.18
Construction In Progress
--162.84269.2658.3445.31
Source: S&P Global Market Intelligence. Standard template. Financial Sources.